文献速递主动脉疾病外周动脉疾病

两种髂动脉分支装置维持髂内动脉血流的中期效果比较

Comparison of Two Iliac Branch Devices and Their Midterm Performance in Maintaining Blood Flow to the Internal Iliac Artery.
PubMed 文献 · J Endovasc Ther · 2020-06-17

该回顾性研究比较了E-liac与Zenith髂动脉分支装置(IBD)在累及髂动脉分叉动脉瘤中保留髂内动脉的中期结局。2014年至2018年共84例患者分别置入E-liac(n=44)或ZBIS(n=40),两组技术成功率、通畅率及再干预率无显著差异。

要点

  • E-liac与ZBIS IBD的技术成功率均高(总体95.9%),组间无统计学差异。
  • 中期免于再干预率与免于闭塞率两组相近,再干预率低。
  • 两种装置在保留髂内动脉血流方面表现相当。

核心结论

  • E-liac与ZBIS两种IBD在技术成功率、中期通畅率及低再干预率方面表现相当。

主要发现

  • 总体技术成功率为95.9%(99例置入中95例成功),E-liac组93.7% vs ZBIS组98.0%(p=0.114)。
  • 术后30天内ZBIS组发生3例闭塞,E-liac组1例;ZBIS组有1例围手术期死亡。
  • 中位随访时间ZBIS组37个月,E-liac组28个月(p=0.657)。
  • Kaplan-Meier估计免于再干预率ZBIS组87.2%(95%CI 82.6%~90.2%),E-liac组86.0%(95%CI 83.7%~89.1%)(p=0.563)。
  • 免于闭塞率ZBIS组89.7%(95%CI 85.8%~94.5%),E-liac组95.3%(95%CI 92%~98.7%)(p=0.317)。

临床怎么用

  • 对于累及髂动脉分叉的动脉瘤,E-liac与ZBIS均可作为保留髂内动脉的可行选择,中期效果相当。

局限性

  • 本研究为回顾性分析,样本量有限,随访时间两组存在差异,且部分患者失访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Purpose: To compare and contrast the midterm outcomes of the E-liac and Zenith (ZBIS) iliac branch devices (IBDs) for the preservation of the internal iliac artery (IIA) in aneurysms involving the iliac bifurcation. Materials and Methods: Between January 2014 and December 2018, 84 consecutive patients (median age 74 years; 76 men) were electively treated with the E-liac (n=44) or ZBIS (n=40) IBDs and were retrospectively analyzed to evaluate the technical success, patency, need for reintervention, and mortality associated with these devices. Results: Technical success was achieved in 95 of 99 implantations (95.9%) without any statistically significant difference between the groups (93.7% vs 98.0%, p=0.114). During the first 30 days, 3 occlusions in the ZBIS group and 1 in the E-liac group were identified. There was 1 perioperative death in the ZBIS group. The median follow-up was 37 months for the ZBIS group and 28 months for the E-liac group (p=0.657). Six patients from the ZBIS group and 7 from the E-liac group were lost to follow-up. Among the remaining, there were 2 further deaths recorded, 1 in each group. Four further reinterventions in the E-liac group and 2 in the ZBIS group were performed during follow-up. The Kaplan-Meier estimates of freedom from reintervention were 87.2% (95% CI 82.6% to 90.2%) for the ZBIS group and at 86.0% (95% CI 83.7% to 89.1%) for the E-liac group (p=0.563); the freedom from occlusion estimates were 89.7% (95% CI 85.8% to 94.5%) and 95.3% (95% CI 92% to 98.7%; p=0.317), respectively. Conclusion: The E-liac and the ZBIS IBDs showed equally high technical success, midterm patency, and low reintervention rates.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Mylonas SN, Ioannides G, Ahmad W, et al. Comparison of Two Iliac Branch Devices and Their Midterm Performance in Maintaining Blood Flow to the Internal Iliac Artery. J Endovasc Ther. 2020. PMID: 32580623. doi:10.1177/1526602820934762

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。